CNBC Investing Club

Investing Club: We're capitalizing on one of our drug stocks' incredible run, selling some shares

Traders work on the floor of the New York Stock Exchange.

We're selling 200 shares of Abbvie (ABBV) at roughly $147.65. Following the trade, we'll own 700 shares of ABBV, decreasing its weighting to 2.68% from 3.42%.

More In CNBC Investing Club Newsletter

CNBC Investing Club3 takeaways from the Investing Club’s ‘Morning Meeting’ on Monday
CNBC Investing ClubNvidia resets expectations with warning of quarterly miss due to gaming weakness
CNBC Investing ClubWhat Cramer is watching Monday — IRA lifts EV and solar stocks, Pfizer's buy